Absci (ABSI) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Absci (ABSI) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | -347.04% |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 73.00% |
| 10 | Absci | 1.19 Bn | 1.06 Bn | - | 27.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.90% |
| Dec 31, 2025 | -1.67% |
| Sep 30, 2025 | -129.42% |
| Jun 30, 2025 | -167.99% |
| Mar 31, 2025 | -1,026.53% |
| Dec 31, 2024 | 89.10% |
| Sep 30, 2024 | 83.50% |
| Jun 30, 2024 | 86.15% |
| Mar 31, 2024 | 95.03% |
| Dec 31, 2023 | -632.79% |
| Sep 30, 2023 | -111.13% |
| Jun 30, 2023 | -331.34% |
| Mar 31, 2023 | -1,159.60% |
| Dec 31, 2022 | -55.03% |
| Sep 30, 2022 | -1,190.47% |
| Jun 30, 2022 | -1,495.07% |
| Mar 31, 2022 | 97.23% |
| Dec 31, 2021 | 314.73% |
| Sep 30, 2021 | 98.48% |
| Jun 30, 2021 | 98.54% |